Bicycle Therapeutics plc (BCYC) Misses Q1 EPS by 3c

Bicycle Therapeutics plc (NASDAQ: BCYC) reported Q1 EPS of ($0.88), $0.03 worse than the analyst estimate of ($0.85). Revenue for the quarter came in at $9.97 million versus the consensus estimate of $8.24 million.

For earnings history and earnings-related data on Bicycle Therapeutics plc (BCYC) click here.

You May Also Be Interested In

• Goldman Sachs Adjust Monthly US Director's Cut List
• Citi cuts SK Hynix price target to KRW3,000,000 on FX pressure
• Citi raises Atlassian price target to $225, maintains Buy rating